Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 5, 2015, Pages 707-716

  Tao, Hui ^a   Yang, Jing Jing ^a   Shi, Kai Hu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac fibrosis; DNA methylation; Epigenetic; Histone modification; Long non coding RNA; MicroRNA

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; UNTRANSLATED RNA; HISTONE;

DISEASE CLASSIFICATION; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; HEART MUSCLE FIBROSIS; HISTONE MODIFICATION; PATHOGENESIS; REVIEW; ANIMAL; FIBROBLAST; FIBROSIS; GENETIC EPIGENESIS; GENETICS; HEART MUSCLE; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HISTONES; HUMANS; MICRORNAS; MYOCARDIUM; RNA, UNTRANSLATED;

EID: 84928472036     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.1001740     Document Type: Review

References (115)

1. Kaikkonen MU, Lam MT, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011;90:430-40
2. d'Adda di Fagagna F. A direct role for small non-coding RNAs in DNA damage response. Trends Cell Biol 2014;24:171-8
3. Peters T, Schroen B. Missing links in cardiology: long non-coding RNAs enter the arena. Pflugers Arch 2014;466(6):1177-87
4. Orenes-Pinero E, Montoro-Garcia S, Patel JV, et al. Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol 2013;167:1651-9
5. Barker PC, Pasquali SK, Darty S, et al. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. Mol Genet Metab 2010;101:332-7
6. Grossniklaus U, Kelly WG, Ferguson-Smith AC, et al. Transgenerational epigenetic inheritance: how important is it? Nat Rev Genetics 2013;14:228-35
7. Sharma A. Transgenerational epigenetic inheritance: focus on soma to germline information transfer. Prog Biophys Mol Biol 2013;113:439-46
8. Viereck J, Bang C, Foinquinos A, et al. Regulatory RNAs and paracrine networks in the heart. Cardiovasc Res 2014;102:290-301
9. Jazbutyte V, Fiedler J, Kneitz S, et al. MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr) 2013;35:747-62
10. Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 2014;1839(8):627-43
11. Leung D, Du T, Wagner U, et al. Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1. Proc Natl Acad Sci USA 2014;111:6690-5
12. Reddy MA, Natarajan R. Role of epigenetic mechanisms in the vascular complications of diabetes. Subcell Biochem 2013;61:435-54
13. Tao H, Yang JJ, Chen ZW, et al. DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology 2014;323C:42-50
14. Ketzer P, Kaufmann JK, Engelhardt S, et al. Artificial riboswitches for gene expression and replication control of DNA and RNA viruses. Proc Natl Acad Sci USA 2014;111:E554-62
15. Kumar B, Kumar P, Rajput R, et al. Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication. Nucleic Acid Ther 2013;23:355-62
16. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genetics 2014;15:7-21
17. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012;111:1349-62
18. Fan D, Takawale A, Basu R, et al. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovasc Res 2014;103(2):268-80
19. de Haas HJ, Arbustini E, Fuster V, et al. Molecular imaging of the cardiac extracellular matrix. Circ Res 2014;114:903-15
20. Sun G, Xue R, Yao F, et al. The critical role of Sestrin 1 in regulating the proliferation of cardiac fibroblasts. Arch Biochem Biophys 2014;542:1-6.
21. Gaspard GJ, MacLean J, Rioux D, et al. A novel beta-adrenergic response element regulates both basal and agonist-induced expression of cyclin-dependent kinase 1 gene in cardiac fibroblasts. Am J Physiol Cell Physiol 2014;306:C540-50
22. Lu D, Aroonsakool N, Yokoyama U, et al. Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis. Mol Pharmacol 2013;84:787-93
23. Zhang X, Guo L, Niu T, et al. Ubiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation. PLoS One 2014;9:e94658.
24. Zhang X, Zhang T, Wu J, et al. Calcium sensing receptor promotes cardiac fibroblast proliferation and extracellular matrix secretion. Cell Physiol Biochem 2014;33:557-68
25. Deb A, Ubil E. Cardiac fibroblast in development and wound healing. J Mol Cell Cardiol 2014;70C:47-55
26. Cilvik SN, Wang JI, Lavine KJ, et al. Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy. PLoS One 2013;8:e82979
27. Chen W, Saxena A, Li N, et al. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol 2012;32:2598-608
28. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014;71:549-74.
29. Dobaczewski M, Frangogiannis NG. Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) 2009;1:391-405
30. van Nieuwenhoven FA, Turner NA. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol 2013;58:182-8
31. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012;110:159-73
32. Katsushima K, Kondo Y. Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation. Front Genet 2014;5:14
33. Iaconetti C, Gareri C, Polimeni A, et al. Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci 2013;14:19987-20018
34. Ounzain S, Crippa S, Pedrazzini T. Small and long non-coding RNAs in cardiac homeostasis and regeneration. Biochim Biophys Acta 2013;1833:923-33
35. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011;10:38
36. Song X, Cao G, Jing L, et al. Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med 2014;18(6):991-1003
37. Shi L, Zhang Z, Yu AM, et al. The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS One 2014;9:e93846
38. Patel T. Extracellular vesicle non-coding RNA - new players in the diagnosis and pathogenesis of cholangiocarcinoma. Hepatology 2014;60(3):782-4
39. Merchen TD, Boesen EI, Gardner JR, et al. Indoleamine 2,3-dioxygenase inhibition alters the non-coding RNA transcriptome following renal ischemia-reperfusion injury. Transpl Immunol 2014;30(4):140-4
40. Wang Y, Gao S, Liu G, et al. Microarray expression profile analysis of long noncoding RNAs in human gastric cardiac adenocarcinoma. Cell Physiol Biochem 2014;33:1225-38
41. Slack FJ. In this issue of epigenetics: special focus on non-coding RNAs in epigenetic regulation. Epigenetics 2014;9:1-2
42. Haga H, Yan I, Takahashi K, et al. Emerging insights into the role of MicroRNAs in the pathogenesis of cholangiocarcinoma. Gene Expr 2014;16:93-9
43. Jeong HJ, Park SY, Yang WM, et al. The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SKHep1 cells. Biochem Biophys Res Commun 2013;434:503-8
44. Das S, Bedja D, Campbell N, et al. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One 2014;9:e96820
45. Bai Z, Huang Y, Li W, et al. Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs. J Virol 2014;88:377-92
46. Wirsing A, Senkel S, Klein-Hitpass L, et al. A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS One 2011;6:e27438
47. Cheng TL, Wang Z, Liao Q, et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/ Drosha complex. Dev Cell 2014;28:547-60
48. Beisel CL, Bloom RJ, Smolke CD. Construction of ligand-responsive microRNAs that operate through inhibition of Drosha processing. Methods Mol Biol 2014;1111:259-67
49. Iyengar BR, Choudhary A, Sarangdhar MA, et al. Non-coding RNA interact to regulate neuronal development and function. Front Cell Neurosci 2014;8:47
50. Hussain M, O'Neill SL, Asgari S. Wolbachia interferes with the intracellular distribution of Argonaute 1 in the dengue vector Aedes aegypti by manipulating the host microRNAs. RNA Biol 2013;10:1868-75
51. Flores O, Kennedy EM, Skalsky RL, et al. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential. Nucleic Acids Res 2014;42:4629-39
52. Shi KH, Tao H, Yang JJ, et al. Role of microRNAs in atrial fibrillation: new insights and perspectives. Cell Signal 2013;25:2079-84
53. Plank M, Maltby S, Mattes J, et al. Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs. Clin Exp Allergy 2013;43:981-99
54. Bang C, Batkai S, Dangwal S, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 2014;124:2136-46
55. Chen S, Puthanveetil P, Feng B, et al. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 2014;18:415-21
56. Nie FQ, Zhu Q, Xu TP, et al. Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol 2014;35(8):7587-94
57. Matsui M, Chu Y, Zhang H, et al. Promoter RNA links transcriptional regulation of inflammatory pathway genes. Nucleic Acids Res 2013;41:10086-109
58. Ilott NE, Ponting CP. Predicting long non-coding RNAs using RNA sequencing. Methods 2013;63:50-9
59. Ng SY, Stanton LW. Long non-coding RNAs in stem cell pluripotency. Wiley Interdiscip Rev RNA 2013;4:121-8
60. Shore AN, Herschkowitz JI, Rosen JM. Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia 2012;17:43-58
61. Knauss JL, Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience 2013;235:200-14
62. Carpenter S, Aiello D, Atianand MK, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013;341:789-92
63. Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010;142:409-19
64. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689-93
65. Lorenzen JM, Martino F, Thum T. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012;107:245
66. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large noncoding RNAs in mammals. Nature 2009;458:223-7
67. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012;81:145-66
68. Necsulea A, Soumillon M, Warnefors M, et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 2014;505:635-40
69. Li G, Zhang H, Wan X, et al. Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma. BioMed Res Int 2014;2014:780521
70. Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol 2010;7:582-5
71. Nagano T, Mitchell JA, Sanz LA, et al. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008;322:1717-20
72. Yang IV, Schwartz DA. Epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol 2012;130:1243-55
73. Furuta Y, Namba-Fukuyo H, Shibata TF, et al. Methylome diversification through changes in DNA methyltransferase sequence specificity. PLoS Genet 2014;10:e1004272
74. Duygu B, Poels EM, da Costa Martins PA. Genetics and epigenetics of arrhythmia and heart failure. Front Genetics 2013;4:219
75. Gray SG. Epigenetic-based immune intervention for rheumatic diseases. Epigenomics 2014;6:253-71
76. Vincent A, Hong SM, Hu C, et al. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget 2014;5(9):2575-87
77. Han F, Dong Y, Liu W, et al. Epigenetic regulation of sox30 is associated with testis development in mice. PLoS One 2014;9:e97203
78. Teif VB, Beshnova DA, Vainshtein Y, et al. Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development. Genome Res 2014;24(8):1285-95
79. Dyachenko OV, Tarlachkov SV, Marinitch DV, et al. Expression of exogenous DNA methyltransferases: application in molecular and cell biology. Biochemistry(Mosc) 2014;79:77-87
80. Tao H, Yang JJ, Shi KH, et al. DNA methylation in cardiac fibrosis: New advances and perspectives. Toxicology 2014;323:125-9
81. Sitaraman R. Helicobacter pylori DNA methyltransferases and the epigenetic field effect in cancerization. Front Microbiol 2014;5:115
82. Talhaoui I, Couve S, Gros L, et al. Aberrant repair initiated by mismatchspecific thymine-DNA glycosylases provides a mechanism for the mutational bias observed in CpG islands. Nucleic Acids Res 2014;42(10):6300-13
83. Xue J, Wijeratne SS, Zempleni J. Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of longterminal repeats. Epigenetics 2013;8:504-11
84. Shimahara H, Hirano T, Ohya K, et al. Nucleosome structural changes induced by binding of non-histone chromosomal proteins HMGN1 and HMGN2. FEBS Open Bio 2013;3:184-91
85. Lan L, Nakajima S, Kapetanaki MG, et al. Monoubiquitinated histone H2A destabilizes photolesion-containing nucleosomes with concomitant release of UV-damaged DNA-binding protein E3 ligase. J Biol Chem 2012;287:12036-49
86. Halley-Stott RP, Gurdon JB. Epigenetic memory in the context of nuclear reprogramming and cancer. Brief Funct Genomics 2013;12:164-73
87. Vire E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006;439:871-4
88. Liu Y, Liu K, Qin S, et al. Epigenetic targets and drug discovery: Part 1: histone methylation. Pharmacol Ther 2014;143(3):275-94
89. Kimura H. Histone modifications for human epigenome analysis. J Hum Genet 2013;58:439-45
90. Tao H, Shi KH, Yang JJ, et al. Epigenetic regulation of cardiac fibrosis. Cell Signal 2013;25:1932-8
91. White R. Packaging the fly genome: domains and dynamics. Brief Funct Genomics 2012;11:347-55
92. Glinsky GV. Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasisenabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 2006;5:1208-16
93. van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012;11:860-72
94. Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009;6:419-29
95. Gomez GG, Wykosky J, Zanca C, et al. Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biol Med 2013;10:192-205
96. Peruzzi P, Bronisz A, Nowicki MO, et al. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro-oncol 2013;15:1212-24
97. Mathiyalagan P, Okabe J, Chang L, et al. The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart. Nucleic Acids Res 2014;42:790-803
98. Yang T, Zhang GF, Chen XF, et al. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2. Biochem Biophys Res Commun 2013;436:578-84
99. Coppola A, Romito A, Borel C, et al. Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. Stem Cell Res 2014;12:323-37
100. Zhu H, Yang Y, Wang Y, et al. MicroRNA-195 promotes palmitateinduced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res 2011;92:75-84
101. Huang ZP, Chen J, Seok HY, et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 2013;112:1234-43
102. Shi H, Chen L, Wang H, et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. Biochem Biophys Res Commun 2013;430:827-32
103. Duan Y, Zhou B, Su H, et al. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300. Exp Cell Res 2013;319:173-84
104. Ghosh AK, Nagpal V, Covington JW, et al. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell Signal 2012;24:1031-6
105. Chavali V, Tyagi SC, Mishra PK. MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem Biophys Res Commun 2012;425:668-72
106. Wamstad JA, Alexander JM, Truty RM, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012;151:206-20
107. Zhou S, Liu Y, Prater K, et al. Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling. Life Sci 2013;93:855-62
108. Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell 2014;157:77-94
109. Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res 2014;114:1377-88
110. Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 2013;24:206-14
111. Wang K, Long B, Zhou LY, et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun 2014;5:3596
112. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010;121:1022-32
113. Malecova B, Morris KV. Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Curr Opin Mol Ther 2010;12:214-22
114. Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011;145:178-81
115. Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 2014;9:3-12